Notably, a recent study identified a dominant negative mutation in the human SLC26A6 gene that impairs the transport function and membrane expression of SLC26A6, representing a significant risk factor for inherited forms of hyperoxaluria and nephrolithiasis [10]. The gene discussed is SLC26A6; the disease is nephrolithiasis.